Extracellular matrix heparan-sulfate-binding proteins (HSBPs)

Extracellular matrix heparan-sulfate-binding proteins (HSBPs) represent a broad functional class of proteins that interact with heparan sulfate (HS) glycosaminoglycans within the extracellular environment. This group includes structural proteins like collagen and laminin, as well as a vast array of signaling molecules such as fibroblast growth factors (FGFs), vascular endothelial growth factors (VEGFs), and various chemokines (PubMed: 25100608). By binding to HS, these proteins are sequestered within the matrix, which protects them from degradation and creates a localized reservoir that regulates their availability to cell-surface receptors (UniProt: P09038). In diseases like cancer, the dysregulation of these interactions—often mediated by the enzyme heparanase—leads to the release of these factors, driving tumor growth, angiogenesis, and metastasis (PubMed: 23412300). Therapeutic interventions often utilize heparin mimetics or small molecules to disrupt these protein-HS interactions or inhibit the enzymes that modify them. While promising for oncology and inflammatory conditions, targeting this broad class requires high specificity to avoid systemic side effects such as impaired coagulation or disrupted tissue repair.

Other names

Heparan sulfate-binding proteinsHeparin-binding proteinsECM-associated HS-binding proteinsHeparan sulfate-interactome

Competitive inhibition of heparan sulfate binding sites, displacement of sequestered growth factors from the extracellular matrix, and inhibition of heparan sulfate-degrading enzymes like heparanase.